Skip to main content

Table 2 Basic characteristics of 622 men according to quartiled Spm concentrationsa

From: Association of glycemic profiles with whole blood polyamine among middle-aged Japanese men: colorimetric assay using oat and barley seedling polyamine oxidase

Basic characteristics of study cohortb

Quartile of Spm concentration (range)

P for effectc

Q1 (≤0.033) (n = 155)

Q2 (≤0.046) (n = 156)

Q3 (≤0.063) (n = 156)

Q4 (>0.063) (n = 155)

Age (years)

49.3 ± 6.3

50.8 ± 6.7

51.4 ± 6.1

51.0 ± 6.0

0.015

Body mass index (kg/m2)

23.1 ± 2.6

23.2 ± 2.6

23.7 ± 2.6

23.5 ± 2.5

0.201

Fasting plasma glucose (mmol/l)

5.58 ± 1.23

5.76 ± 1.20

5.85 ± 1.33

5.85 ± 1.21

0.195

Fasting plasma insulin (μU/ml)

5.57 ± 3.03

5.51 ± 2.94

6.54 ± 6.40

6.14 ± 5.80

0.186

HOMA–IRd

1.39 ± 0.80

1.43 ± 0.86

1.67 ± 1.45

1.60 ± 1.55

0.119

Fructosamine (μmol/l)

257 ± 37

253 ± 31

257 ± 39

256 ± 40

0.732

Polyamine-to-hemoglobin ratio (μmol/g)

 Spd + Spm

0.76 ± 0.32

0.94 ± 0.24

1.16 ± 0.81

1.35 ± 0.63

<0.001

 Spm

0.23 ± 0.11

0.39 ± 0.04

0.54 ± 0.05

0.91 ± 0.56

<0.001

Smoking status (% of subjects)

 Never

32.3

39.7

35.3

32.3

0.831

 Past

22.6

20.5

23.1

24.5

 

 Current

45.2

39.7

41.7

43.2

 

Drinking status (% of subjects)

 None

25.8

26.3

35.9

30.3

0.061

 Light

28.4

26.9

14.1

23.2

 

 Moderate

22.6

16.7

25.0

19.4

 

 Moderate

23.2

30.1

25.0

27.1

 

Leisure-time physical activity (% of subjects)

 Not very active

81.6

77.3

75.0

77.0

0.726

 Somewhat active

10.4

14.3

16.7

16.4

 

 Regularly active

7.8

8.4

8.3

6.6

 

Present history of chronic disease (% of subjects)e

 Yes

14.8

19.9

15.4

20.0

0.472

  1. Spm, Spermine
  2. aQuartiled Spm + Spd concentrations are represented by polyamine-to-hemoglobin ratio
  3. bValues in the upper part of the table only are given as means ± standard deviation
  4. cP value by one-factor analysis of variance for continuous variables, and chi-square test for categorical variables
  5. dHomeostasis model assessment–insulin resistance
  6. eAny disease under treatment, including hypertension, diabetes, dyslipidemia, stroke, heart disease, or hyperuricemia